Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/1996
12/27/1996EP0749434A1 Benzothiophene, benzofuran and indolethiazepinones, oxazepinones and diazepinones as inhibitors of cell adhesion and as inhibitors of hiv
12/27/1996EP0749428A1 Isoxazoline compounds as inhibitors of tnf release
12/27/1996EP0749421A1 Sulphonamide derivatives as aspartyl protease inhibitors
12/27/1996EP0749323A1 Methods for modulating t cell unresponsiveness
12/27/1996EP0749322A1 VACUOLATING TOXIN-DEFICIENT $i(H. PYLORI) AND RELATED METHODS
12/27/1996EP0749321A1 Active immunization using a siderophore receptor protein
12/27/1996EP0749319A1 Immortalized cells and uses therefor
12/27/1996EP0749317A1 Therapeutic uses of bactericidal/permeability-increasing protein dimer products
12/27/1996EP0749314A1 Method for treating and inhibiting gastric and duodenal ulcers
12/27/1996EP0664833B1 Therapeutic anti-hiv oligonucleotide and pharmaceutical
12/27/1996EP0633784B1 Hepatitis vaccins containing 3-0 deacylated monophosphoryl lipid A
12/27/1996EP0625190B1 New bacterium causing poultry disease and vaccine derived thereof
12/27/1996EP0610265B1 Substituted aryl- and heteroarylphenyloxazolidinones useful as antibacterial agents
12/27/1996EP0580641B1 New thalidomide derivatives, method of manufacture and use thereof in medicaments
12/27/1996EP0500835B1 A novel quinolone carboxylic acid derivative
12/27/1996CA2253496A1 Adherence gene from helicobacter pylori and polypeptide coded thereby
12/27/1996CA2224563A1 Combination of a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist for the treatment of inflammations
12/27/1996CA2224517A1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor
12/27/1996CA2224379A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene a4 hydrolase inhibitor
12/25/1996CN1138862A Watersoluble azole antifungals
12/25/1996CN1138861A 2-heteroaryl-5,11-dihydro-6H-dipyrido|3,2-b:2',3'-3¨|1,4¨diazepines and their use in the prevention or treatment of HIV infection
12/25/1996CN1138826A Microgranules of 5-nitro imidazole derivatives
12/25/1996CN1138588A Phosphonomonoester nucleic acids, process for their preparation, and their use
12/25/1996CN1138582A heteroatom-comtaining benzocyclopentane-oxazolidinones
12/25/1996CN1138572A Application of Ubimec medicinal compsn. or containing ubimec for treatment virus hepatitis
12/25/1996CN1138474A Antissepsis, antiinflammation and hemostasis capsules
12/25/1996CN1033645C Oleandomycin oximes, prepn. and use thereof
12/25/1996CN1033640C 2-substituted-5-substituted-1, 3-oxathiolanes with antiviral properties
12/25/1996CN1033638C Novel alpha-mannosidase and fucosidase inhibitors
12/24/1996US5587495 4-substituted anthracyclinones and anthracycline glycosides and the process for preparing them
12/24/1996US5587481 Preparation of (S)-decahydroisoquinoline-3-carboxylic acid t-butylamide
12/24/1996US5587480 Treating hiv and hepatitis virus infections
12/24/1996US5587473 Blocking; condensation; deblocking
12/24/1996US5587469 Oligonucleotides containing N-2 substituted purines
12/24/1996US5587389 Substituted heteroarylaklylthiopyridines for controlling helicobacter bacteria
12/24/1996US5587388 Irreversible HIV protease inhibitors, intermediates, compositions and processes for the preparation thereof
12/24/1996US5587386 Optically active pyridonecarboxylic acid derivatives
12/24/1996US5587374 Bactericides treating infections
12/24/1996US5587373 Elastase inhibitors
12/24/1996US5587362 L-nucleosides
12/24/1996US5587358 Potentiators of antimicrobial activity
12/24/1996US5587314 Intestine colonizing lactobacilli
12/24/1996US5587164 Vaccine for protection against porcine reproductive and respiratory disease
12/20/1996CA2179426A1 Use of ligands specific to rxr receptors
12/19/1996WO1996041179A1 Expression system for non-secretor genes
12/19/1996WO1996040977A1 Origin of replication complex genes
12/19/1996WO1996040953A1 Genetically altered feline immunodeficiency viruses and their use as an effective vaccine against feline immunodeficiency virus infection
12/19/1996WO1996040948A2 RESISTANCE TO VIRUSES AND VIROIDS IN TRANSGENIC PLANT AND ANIMAL HOSTS EXPRESSING dsRNA-BINDING PROTEIN
12/19/1996WO1996040945A2 Nucleic acid respiratory syncytial virus vaccines
12/19/1996WO1996040940A2 A human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases
12/19/1996WO1996040932A1 Vaccine for porcine reproductive and respiratory syndrome virus
12/19/1996WO1996040931A1 Neutralizing conformational epitopes of chicken anemia virus
12/19/1996WO1996040930A1 Mutants of streptococcal toxin a and methods of use
12/19/1996WO1996040929A2 Transferrin receptor genes
12/19/1996WO1996040928A1 Streptococcal heat shock proteins members of the hsp70 family
12/19/1996WO1996040903A1 Macrophage activating factors derived from cloned vitamin d binding protein
12/19/1996WO1996040898A1 Triple-helix forming oligonucleotides for targeted mutagenesis
12/19/1996WO1996040880A1 Recombinant fowlpox viruses and uses thereof
12/19/1996WO1996040872A1 Bile duct progenitor cells and methods of use
12/19/1996WO1996040795A1 Antigenic group b streptococcus type ii and type iii polysaccharide fragments having a 2, 5-anhydro-d-mannose terminal structure and conjugate vaccine thereof
12/19/1996WO1996040770A2 Anti-fungal d-amino acid histatin-based peptides
12/19/1996WO1996040768A2 Anti-fungal and anti-bacterial histatin-based peptides
12/19/1996WO1996040737A1 Reversible cysteine protease inhibitors
12/19/1996WO1996040728A2 Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (nhe), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the nhe-inhibitory efficacy of compounds
12/19/1996WO1996040711A1 Cross-linking oligonucleotides
12/19/1996WO1996040686A1 Heterocyclic substituted cyclopentane compounds
12/19/1996WO1996040683A1 Novel derivatives of swainsonine, processes for their preparation and their use as therapeutic agents
12/19/1996WO1996040668A2 Small molecule inhibition of rna/ligand binding
12/19/1996WO1996040647A1 α-(1,3-DICARBONYLENOL ETHER) METHYL KETONES AS CYSTEINE PROTEASE INHIBITORS
12/19/1996WO1996040627A2 Thiocationic lipids, pharmaceutical compositions and methods of use thereof
12/19/1996WO1996040290A1 Immunological combination compositions and methods
12/19/1996WO1996040268A1 Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
12/19/1996WO1996040252A1 High affinity human monoclonal antibodies specific for rsv f-protein
12/19/1996WO1996040242A1 Vaccine comprising a polysaccharide antigen-carrier protein conjugate and free carrier protein
12/19/1996WO1996040241A1 Recombinant poxvirus-rabies compositions and combination compositions and uses
12/19/1996WO1996040239A1 Modified meningococcal polysaccharide conjugate vaccines
12/19/1996WO1996040238A1 Vectors for the diagnosis and treatment of solid tumors including melanoma
12/19/1996WO1996040237A1 Actinomyces pyogenes and actinomyces pyogenes/fusobacterium necrophorum vaccines for immunizing cattle and sheep
12/19/1996WO1996040234A1 In ovo vaccination against coccidiosis
12/19/1996WO1996040225A1 Immunogenic and immunostimulatory oligosaccharide compositions and methods of making and using them
12/19/1996WO1996040191A1 The treatment of hiv and other viral infections using combinatory therapy
12/19/1996WO1996040179A1 Method of improving animal health
12/19/1996WO1996040169A1 Bacterial inhibition with an oligosaccharide compound
12/19/1996WO1996040164A1 Nucleosides with anti-hepatitis b virus activity
12/19/1996WO1996040159A1 Capped synthetic rna, analogs, and aptamers
12/19/1996WO1996040157A1 USE OF ANTISENSE OLIGONUCLEOTIDES TO IL-6 RECEPTOR mRNA TO INHIBIT CELLULAR PROLIFERATION
12/19/1996WO1996040145A1 Methods of combatting infectious diseases using dicationic bis-benzimidazoles
12/19/1996WO1996040143A1 Imidazole compounds
12/19/1996WO1996040130A1 Methods of inducing bef-1 transcription factor
12/19/1996WO1996040125A1 Anti-viral compounds
12/19/1996WO1996040124A1 Anti-viral compounds
12/19/1996WO1996040120A1 Use of bis-1,2,4-triazoles for the manufacture of a medicament for the treatment of cancers
12/19/1996WO1996040117A1 Methods of treating microbial infections
12/19/1996WO1996040114A1 Methods of inhibiting pneumocystis carinii pneumonia and compounds useful therefor
12/19/1996WO1996040088A1 Acyclovir derivatives for topical use
12/19/1996WO1996040056A1 Polyether block copolymer micellar compositions for targeting biological agents
12/19/1996WO1996039838A1 Methods of inhibiting bacterial sialidase
12/19/1996WO1996039831A1 Prodrugs of pharmaceuticals with improved bioavailability
12/19/1996DE19521705A1 Immunogenes Konstrukt, Verfahren zu dessen Herstellung und Verwendung als Vakzine An immunogenic construct, a process for its preparation and use as a vaccine
12/19/1996DE19521314A1 Adhärenzgen aus Helicobacter pylori und davon codiertes Polypeptid Adhärenzgen from Helicobacter pylori and it polypeptide encoded
1 ... 1596 1597 1598 1599 1600 1601 1602 1603 1604 1605 1606 1607 1608 1609 1610 1611 1612 1613 1614 1615 1616 ... 1798